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EDITORIAL COMMENT
This study is very welcome as it demonstrates 
the high rate of human papillomavirus (HPV) associ-
ated with penile cancer. The detection rate of 75% 
approaches the rate of 90% seen in carcinoma in-situ. 
Other studies show lower HPV rates. It was unclear 
if this was due to differences in technique, such as 
immunohistochemistry or due to real variations in 
biology. Furthermore, the lower rate of HPV (50%) 
in verrucous type indicates a possible different etiol-
ogy to this subset of cancer. Studying the subtypes 
of HPV associated with penile cancer is paramount 
currently, given the recent development of vaccines 
DJDLQVWVSHFL¿FVXEW\SHVRI+39,WLVKDUGWRSURMHFW
the effect mass vaccination of females will have on 
males, but ought to reduce carriage of HPV among 
heterosexual males. Vaccinating males may have 
EHQH¿WV IRU IHPDOHV DOVR DV WRWDO LPPXQL]DWLRQRI
the whole female population is unlikely. Reduc-
ing the overall population pool of these subtypes is 
OLNHO\WREHQH¿WERWKPDOHVDQGIHPDOHV7KHLPSDFW
on the incidence and type of penile cancer is likely 
have a lead time of several decades, as only a quar-
ter of men with penile cancer present under the age 
of 50. Projections must also take into account the 
increasing life-expectancies in developed countries 
with more men living into their 70s and 80s, where 
the disease is more prevalent (see http:// www.oecd.
org/statsportal/). Thus in the absence of any vaccina-
tion the prevalence is likely to increase, whereas even 
with successful vaccination changes in demographics 
PD\UHGXFHWKHEHQH¿WLQWKHLQLWLDO\HDUV)LQDOO\WKH
subtypes of HPV being targeted may result in only 
some cancers being prevented. These factors must be 
brought together in modeling and scenario planning 
when formulating strategies for service provision in 
any healthcare system.
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EDITORIAL COMMENT
The prevalence of penile cancer in Brazil 
is 2% and this is higher than in the USA and Eu-
rope, where it accounts for 0.3 to 0.6% of cancers 
(1,2). Squamous cell carcinoma (SCC) is the most 
common histological type of penile cancer and 
represents 95% of cases. However the aetiology of 
penile cancer is unknown, risk factors include age 
and lack of circumcision (1,2). Other predispos-
ing factors to the development of penile SCC are 
the chronic inflammatory disorder penile lichen 
sclerosus (LS) (also termed balanitis xerotica 
obliterans) (3-6) or human papillomavirus (HPV) 
infection (1,2,7,8). A common aetiology for penile 
and cervical cancer is suggested by the geographi-
cal correlation between the incidence of penile 
and cervical cancers worldwide (9). The persistent 
infection with sexually transmitted high risk HPV 
is the main cause of cervical cancer (10,11). The 
prevalence of HPV penile infections in healthy men 
is reported to be 39% in Brazil and 3-9% in Western 
Europe, where there is a lower incidence of penile 
cancer (12,13). However, HPV detection in penile 
cancer cases varies from 20-80%, depending on 
detection method and geographical location (1,2). 
This is unlike cervical cancer where HPV infection 
can be detected in almost all cases (10).
The paper entitled “Human Papillomavirus 
and Penile Cancers in Rio de Janeiro, Brazil: HPV 
Typing and Clinical Features” concerns penile can-
cer HPV infection and survival in 80 consecutive 
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cases of patients who underwent surgery at Hospi-
tals in Rio de Janeiro between 1995 and 2000. High 
risk HPV 16 was the predominate HPV type detect-
ed and no correlation was observed between HPV 
status (all types) and penile cancer subtype, stage, 
regional metastases or survival. HPV 16 has previ-
ously been reported to predominate in penile lichen 
sclerosus and SCC and may be an aetiological agent 
LQ WKH GHYHORSPHQW RI D VLJQL¿FDQW SURSRUWLRQ RI
penile cancers (7,14). However the importance of 
HPV status in penile cancer progression and patient 
survival is controversial, as high-risk HPV is asso-
ciated with aggressive variants (8) but recent series 
examining the relationship of HPV infection with 
prognosis have revealed either no correlation sur-
vival or a favourable survival (15,16). This study 
from Rio de Janeiro is consistent with only inguinal 
metastasis being a prognostic factor for penile can-
cer survival. In summary, high risk HPV infection 
occurs in penile SCC and it is likely to be an ae-
WLRORJLFDODJHQWLQWKHGHYHORSPHQWRIDVLJQL¿FDQW
proportion of penile cancers. These results are im-
portant as prophylactic HPV vaccines for preven-
tion of cervical cancer in women could also prevent 
penile cancers in men. However, several studies, 
including this one, show that once penile cancer 
has developed poor prognosis is associated with the 
occurrence of lymph node metastasis and not HPV 
status.
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